Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
A potent hepatitis B surface antigen response in subjects with inactive hepatitis B surface antigen carrier treated with pegylated‐interferon alpha
Cao, Zhenhuan, Liu, Yali, Ma, Lina, Lu, Junfeng, Jin, Yi, Ren, Shan, He, Zhimin, Shen, Chengli, Chen, Xinyue
Published in Hepatology (Baltimore, Md.) (01.10.2017)
Published in Hepatology (Baltimore, Md.) (01.10.2017)
Get full text
Journal Article
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea
Yacoub, Abdulraheem, Mascarenhas, John, Kosiorek, Heidi, Prchal, Josef T., Berenzon, Dmitry, Baer, Maria R., Ritchie, Ellen, Silver, Richard T., Kessler, Craig, Winton, Elliott, Finazzi, Maria Chiara, Rambaldi, Alessandro, Vannucchi, Alessandro M., Leibowitz, David, Rondelli, Damiano, Arcasoy, Murat O., Catchatourian, Rosalind, Vadakara, Joseph, Rosti, Vittorio, Hexner, Elizabeth, Kremyanskaya, Marina, Sandy, Lonette, Tripodi, Joseph, Najfeld, Vesna, Farnoud, Noushin, Papaemmanuil, Elli, Salama, Mohamed, Singer-Weinberg, Rona, Rampal, Raajit, Goldberg, Judith D., Barbui, Tiziano, Mesa, Ruben, Dueck, Amylou C., Hoffman, Ronald
Published in Blood (31.10.2019)
Published in Blood (31.10.2019)
Get full text
Journal Article
Effectiveness of Pegylated Interferon Alpha-2a in Post-Uveitic Macular Edema Previously Responding to Non-Pegylated Interferon
De Simone, L., Gentile, P., Aldigeri, R., Mastrofilippo, V., Bolletta, E., Gozzi, F., Adani, C., Salvarani, C., Cimino, L.
Published in Ocular immunology and inflammation (01.07.2024)
Published in Ocular immunology and inflammation (01.07.2024)
Get full text
Journal Article
Efficacy and safety of pegylated interferon alfa-2b in moderate COVID-19: A phase II, randomized, controlled, open-label study
Pandit, Anuja, Bhalani, Nirav, Bhushan, B.L. Shashi, Koradia, Parshottam, Gargiya, Shweta, Bhomia, Vinay, Kansagra, Kevinkumar
Published in International journal of infectious diseases (01.04.2021)
Published in International journal of infectious diseases (01.04.2021)
Get full text
Journal Article
Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
Bhushan B L, Shashi, Wanve, Sunil, Koradia, Parshottam, Bhomia, Vinay, Soni, Pravin, Chakraborty, Sisir, Khobragade, Akash, Joshi, Shashank, Mendiratta, Sanjeev Kumar, Kansagra, Kevin Kumar, Parihar, Anurag, Sharma, Sunil, Patel, Jatin
Published in International journal of infectious diseases (01.10.2021)
Published in International journal of infectious diseases (01.10.2021)
Get full text
Journal Article
Pegylated Interferon Alfa-2a Monotherapy Results in Suppression of HIV Type 1 Replication and Decreased Cell-Associated HIV DNA Integration
Azzoni, Livio, Foulkes, Andrea S., Papasavvas, Emmanouil, Mexas, Angela M., Lynn, Kenneth M., Mounzer, Karam, Tebas, Pablo, Jacobson, Jeffrey M., Frank, Ian, Busch, Michael P., Deeks, Steven G., Carrington, Mary, O'Doherty, Una, Kostman, Jay, Montaner, Luis J.
Published in The Journal of infectious diseases (15.01.2013)
Published in The Journal of infectious diseases (15.01.2013)
Get full text
Journal Article
Pegylated interferon α therapy in acute hepatitis C: Relation to hepatitis C virus–specific T cell response kinetics
Kamal, Sanaa M., Ismail, Alaa, Graham, Camilla S., He, Qi, Rasenack, Jens W., Peters, Thomas, Tawil, Ahmed A., Fehr, Jutta J., Khalifa, Khalifa El Sayed, Madwar, Mahmoud M., Koziel, Margaret James
Published in Hepatology (Baltimore, Md.) (01.06.2004)
Published in Hepatology (Baltimore, Md.) (01.06.2004)
Get full text
Journal Article
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
Lindsay, Karen L., Trepo, Christian, Heintges, Tobias, Shiffman, Mitchell L., Gordon, Stuart C., Hoefs, John C., Schiff, Eugene R., Goodman, Zachary D., Laughlin, Mark, Yao, Ruji, Albrecht, Janice K.
Published in Hepatology (Baltimore, Md.) (01.08.2001)
Published in Hepatology (Baltimore, Md.) (01.08.2001)
Get full text
Journal Article
Allergic sensitization to pegylated interferon‐α results in drug eruptions
Meller, S., Gerber, P. A., Kislat, A., Hevezi, P., Göbel, T., Wiesner, U., Kellermann, S., Bünemann, E., Zlotnik, A., Häussinger, D., Erhardt, A., Homey, B.
Published in Allergy (Copenhagen) (01.07.2015)
Published in Allergy (Copenhagen) (01.07.2015)
Get full text
Journal Article
THU-260 IM-PROVE I: characterization of chronic hepatitis B (CHB) subjects with functional cure or HBV DNA suppression after completion of imdusiran plus short courses of pegylated interferon alfa-2a (IFN) and discontinuation of nucleos(t)ide analogue (NA) therapy
Yuen, Man-Fung, Nahass, Ronald G., Wong, Grace Lai-Hung, Burda, Tatiana, Nguyen, Tuan T., Lim, Young-Suk, Chuang, Wan-Long, Schiff, Eugene R., Bhamidimarri, Kalyan, Gray, Kevin, Thi, Emily P., Espiritu, Christine L., Medvedeva, Elina, Eley, Timothy, Anderson, Mark, Fortney, Tiffany, Cloherty, Gavin, Sims, Karen D.
Published in Journal of hepatology (01.05.2025)
Published in Journal of hepatology (01.05.2025)
Get full text
Journal Article
THU-253 IM-PROVE I: Rapid loss followed by transient increases in HBV RNA in chronic hepatitis B subjects during treatment with imdusiran and pegylated interferon alfa-2a is associated with HBsAg seroclearance
Espiritu, Christine L., Eley, Timothy, Gray, Kevin, Anderson, Mark, Fortney, Tiffany, Cloherty, Gavin, Medvedeva, Elina, Yuen, Man-Fung, Heo, Jeong, Nahass, Ronald G., Wong, Grace Lai-Hung, Burda, Tatiana, Bhamidimarri, Kalyan, Hu, Tsung-Hui, Nguyen, Tuan T., Lim, Young-Suk, Chen, Chi-Yi, Gordon, Stuart C., Holmes, Jacinta, Chuang, Wan-Long, Kohli, Anita, Alkhouri, Naim, Lam, Angela M., Sofia, Michael J., Sims, Karen D., Thi, Emily P.
Published in Journal of hepatology (01.05.2025)
Published in Journal of hepatology (01.05.2025)
Get full text
Journal Article
LBP-38 - Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection
Yuen, Man-Fung, Heo, Jeong, Nahass, Ronald G, Wong, Grace Lai-Hung, Burda, Tatiana, Bhamidimarri, Kalyan Ram, Hu, Tsung-Hui, Nguyen, Tuan, Lim, Young-Suk, Chen, Chi-Yi, Gordon, Stuart C, Holmes, Jacinta, Chuang, Wan-Long, Kohli, Anita, Alkhouri, Naim, Gray, Kevin, Thi, Emily P., Medvedeva, Elina, Eley, Timothy, Sims, Karen
Published in Journal of hepatology (01.06.2023)
Published in Journal of hepatology (01.06.2023)
Get full text
Journal Article
Preliminary safety and antiviral activity of AB-729 combination treatment with pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection
Yuen, Man-Fung, Heo, Jeong, Nahass, Ronald G, Wong, Grace Lai-Hung, Burda, Tatiana, Bhamidimarri, Kalyan Ram, Hu, Tsung-Hui, Nguyen, Tuan, Lim, Young-Suk, Chen, Chi-Yi, Gordon, Stuart C, Holmes, Jacinta, Chuang, Wan-Long, Kohli, Anita, Alkhouri, Naim, Gray, Kevin, Thi, Emily P., Medvedeva, Elina, Eley, Timothy, Sims, Karen
Published in Journal of hepatology (01.06.2023)
Published in Journal of hepatology (01.06.2023)
Get full text
Journal Article
WED-371 Imdusiran (AB-729) administered every 8 weeks in combination with 24 weeks of pegylated interferon alfa-2a in virally suppressed, HBeAg-negative subjects with chronic HBV infection leads to HBsAg loss in some subjects at end of IFN treatment
Yuen, Man-Fung, Heo, Jeong, Nahass, Ronald G., Wong, Grace Lai-Hung, Burda, Tatiana, Bhamidimarri, Kalyan Ram, Hu, Tsung-Hui, Nguyen, Tuan T., Lim, Young-Suk, Chen, Chi-Yi, Gordon, Stuart C., Holmes, Jacinta, Chuang, Wan-Long, Kohli, Anita, Alkhouri, Naim, Gray, Kevin, Thi, Emily P., Medvedeva, Elina, Eley, Timothy, Ganchua, Sharie C., Iott, Christina, Eill, Elizabeth, Espiritu, Christine L., Anderson, Mark, Fortney, Tiffany, Cloherty, Gavin, Sims, Karen D.
Published in Journal of hepatology (01.06.2024)
Published in Journal of hepatology (01.06.2024)
Get full text
Journal Article
Long Term Clinical and Molecular Responses in Patients with Polycythemia Vera and Essential Thrombocytosis Receiving Pegylated Interferon-Alpha Therapy
Diebolt, Leah, Twardowski, Nicole, Esplund, Jayda, Wu, Jianzheng, Pal Mudaranthakam, Dinesh, Yacoub, Abdulraheem
Published in Blood (05.11.2024)
Published in Blood (05.11.2024)
Get full text
Journal Article
Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome
Keskin, Onur, Wedemeyer, Heiner, Tüzün, Ali, Zachou, Kalliopi, Deda, Xheni, Dalekos, George N., Heidrich, Benjamin, Pehlivan, Selcen, Zeuzem, Stefan, Yalçın, Kendal, Gürel, Selim, Tabak, Fehmi, Idilman, Ramazan, Bozkaya, Hakan, Manns, Michael, Yurdaydin, Cihan
Published in Clinical gastroenterology and hepatology (01.12.2015)
Published in Clinical gastroenterology and hepatology (01.12.2015)
Get full text
Journal Article
Allergic sensitization to pegylated interferon-[alpha] results in drug eruptions
Meller, S, Gerber, P A, Kislat, A, Hevezi, P, Gobel, T, Wiesner, U, Kellermann, S, Bunemann, E, Zlotnik, A, Haussinger, D, Erhardt, A, Homey, B
Published in Allergy (Copenhagen) (01.07.2015)
Published in Allergy (Copenhagen) (01.07.2015)
Get full text
Journal Article
Pegylated interferon for chronic hepatitis C in children affects growth and body composition: Results from the pediatric study of hepatitis C (PEDS-C) trial
Jonas, Maureen M., Balistreri, William, Gonzalez-Peralta, Regino P., Haber, Barbara, Lobritto, Steven, Mohan, Parvathi, Molleston, Jean P., Murray, Karen F., Narkewicz, Michael R., Rosenthal, Philip, Schwarz, Kathleen B., Barton, Bruce A., Shepherd, John A., Mitchell, Paul D., Duggan, Christopher
Published in Hepatology (Baltimore, Md.) (01.08.2012)
Published in Hepatology (Baltimore, Md.) (01.08.2012)
Get full text
Journal Article
Silybin supplementation during HCV therapy with pegylated interferon-[alpha] plus ribavirin reduces depression and anxiety and increases work ability
Malaguarnera, Giulia, Be, Chisari, Giuseppe, Motta, Massimo, Vecchio, Michele, Vacante, Marco, Caraci, Filippo, Greco, Carmela, Drago, Filippo, Nunnari, Giuseppe, Malaguarnera, Michele
Published in BMC psychiatry (15.11.2016)
Published in BMC psychiatry (15.11.2016)
Get full text
Journal Article